Navigation Links
Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018
Date:8/11/2009

WALTHAM, Mass., Aug. 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the entry and uptake of premium-priced biologics will drive the systemic lupus erythematosus drug market to more than quadruple from approximately $420 million in 2008 to nearly $2 billion in 2018.

The new Pharmacor report entitled Systemic Lupus Erythematosus finds that the primary drivers of market growth will be the entry and uptake of Human Genome Sciences/GlaxoSmithKline's Benlysta, Biogen Idec/Roche's ocrelizumab, and Immunomedics/UCB's epratuzumab. In 2018, these three agents, combined with the continued uptake of rituximab (Biogen Idec/Roche/Chugai/Zenyaku Kogyo's Rituxan, Roche's MabThera), will account for more than 80 percent of sales in the systemic lupus erythematosus drug market. In 2008, the market was characterized by extensive use of generics and the majority of sales were driven by the off-label use of two branded agents -- Roche/Galenica's CellCept and rituximab. The off-label use of CellCept, rituximab and other therapies exemplifies the unusual dynamics of the systemic lupus erythematosus market.

"The continued uptake of rituximab, despite its failure in recent clinical trials, highlights the significant challenges associated with drug development for systemic lupus erythematosus, the high unmet need in the indication and the unusual dynamics of this market," said Decision Resources Analyst Dancella Fernandes, Ph.D. "Rituximab's contribution to growth will be greater in the near-term but, from 2013 to 2018, its sales will decline modestly as biosimilar versions of the drug emerge in Europe in 2013 and in the United States in 2015."

The report also finds that the partial replacement of current, predominantly generic, immunosuppressants by branded, premium-priced immunosuppressants will also
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
2. Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
3. China Biologic Products Hosts its First Forum for Strategy and Development
4. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
5. MicroFluidic Systems (MFSI) Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis.
6. CQ Forum on Biosimilar Biological Products - Wed., June 17, 2009
7. China Biologic Products Closes the $9.6 Million Private Placement
8. China Biologic Products Enters Into Private Placement Agreements to Raise $9.6 Million
9. ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema
10. Results From Neurotechs NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors
11. Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... 18, 2014 BioElectronics Corporation (OTC ... medical devices said that its EVP Dr. ... CEOLIVE.TV as part of its Executive Interview ... available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... investors the unique advantages of BioElectronics patented ...
(Date:8/18/2014)... devices with unprecedented efficiency and data storage ... use built-in electric polarizations to read and ... most popular data-driven technology. But ferroelectrics must ... including a curious habit of "forgetting" stored ... U.S. Department of Energy,s Brookhaven National Laboratory ...
(Date:8/18/2014)... YORK , August 18, 2014 ... published by Transparency Market Research "Life Science Reagents ... Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and ... and Academic Institutions, Clinical Laboratories, and Forensic Laboratories)- ... Forecast, 2013 - 2019", the global life science ...
(Date:8/18/2014)... 2014 TNI BioTech, Inc. (OTC-BB: TNIB) ("we" ... and marketing of innovative therapies for autoimmune diseases in ... a second notice of TNI BioTech,s annual meeting of ... Noreen Griffin , founder and CEO of TNI ... participation in the Annual Meeting. On behalf of our ...
Breaking Biology Technology:BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 2TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 3TNI BioTech Inc., provides 2nd Notice of Annual Meeting September 4, 2014 4
... March 20 PharmAthene, Inc.,(Amex: PIP ) ... chemical threats, today reported the company will delay ... 31, 2007. The earnings,release was previously scheduled for ... date and time of its earnings release and ...
... (NASDAQ: ANPI , TSX: ANP), a global ... participate in the Credit Suisse,Global Leveraged Finance Conference, ... Mr. Thomas Bailey, Angiotech,s Chief Financial Officer, ... at approximately 8:00 am Mountain,Time. A question and ...
... S.C., March 20 On January 7,2008, Signalife ... ("AMEX") pursuant to which it advised that Signalife ... equity threshold required for,continued listing under AMEX Rules ... Signalife,s market capitalization to less than,$50 million, which ...
Cached Biology Technology:AMEX Notifies Signalife That It Has Accepted Signalife's Plan of Compliance 2
(Date:8/20/2014)... discovered that acral melanomas the rare type of skin ... genetically distinct from other more common types of skin cancer, ... journal Pigment Cell & Melanoma Research . , Acral ... of the feet, nail-beds and other hairless parts of the ... caused by UV damage from the sun. , The team, ...
(Date:8/20/2014)... Biting into a chili pepper causes a burning spiciness ... Scientists exploring the chili pepper,s effect are using their ... kinds of pain, which can be caused by inflammation ... compound, which is being tested in clinical trials, in ... Tafesse and colleagues explain that decades ago, scientists had ...
(Date:8/20/2014)... poor experience higher cortisol levels in pregnancy and give ... hormone, putting them at greater risk for serious ... from the University of Colorado Denver. , The study, ... Human Biology , is the first to measure cortisol ... status of their mothers during pregnancy. , "There have ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2CU Denver researcher shows economic disparities impact infant health 2
... The old excuse, "I am only overweight because ... uncover ever more evidence that the way our bodies ... is different for every person. The budding discipline of ... manner. Nutrition scientists and food chemists at the Technische ...
... published today in Science , researchers from Cambridge, ... plasticity in how transcription factors, the proteins that bind ... their function over large evolutionary distances. The text ... that they regulate by binding to short, sequence-specific lengths ...
... Coral reef ecosystems are highly valued for ... multibillion dollar reef fishing and tourism industries, but ... growth and over-exploitation. The National Institute ... accepting applications for its Investigative Workshop, Modeling Reef ...
Cached Biology News:Metabolic fingerprints offer fresh clues and a new path toward personalized medicine 2Metabolic fingerprints offer fresh clues and a new path toward personalized medicine 3Rewiring of gene regulation across 300 million years of evolution 2
... routine agarose gel electrophoresis into an automated, ... This bufferless, pre-cast system is ideal for ... digests, and more. Fully automated, robot-compatible, and ... 96 system makes your high-throughput screening assignments ...
SpectroQuest single beam 4nm UV/Vis spectrophotometer; stand-alone unit; large angled LCD screen; large sample compartment...
... PCR Cloning Kit, 40 reactions. Optimized ... of all PCR products with blunt ... approaches by offering consistently better signal-to-noise ... more positive clones.Amplicons generated by proof-reading ...
... Clone/PAD: ZMD.368. Immunogen: Synthetic ... of the human WNT2B/WNT13 protein. ... human mouse and rat WNT2B/WNT13 proteins. ... isoforms. Reactivity: Mouse Human Rat ...
Biology Products: